A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.
Do you agree with the decision to send weapons, soldier and ships to the Middle East as a deterrent in the Israel-Hamas war?
Zepbound is the latest diabetes drug approved for weight loss, joining Novo Nordisk’s Wegovy, a high-dose version of its diabetes treatment Ozempic. “This would be the most highly efficacious drug ever approved for the treatment of obesity,” said Dr. Fatima Cody Stanford, an obesity medicine expert at Massachusetts General Hospital in Boston.
While experts lauded approval of Zepbound, they worried that it wouldn’t necessarily mean greater access to the drug, which has been prescribed “off-label” to help people pare pounds.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves new version of diabetes drug Mounjaro for weight lossFederal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug
Read more »
FDA approves new version of diabetes drug Mounjaro for weight lossFederal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug. The Food and Drug Administration approved Zepbound on Wednesday. The drug has been shown to help dieters lose about a quarter of their body weight, or 60 pounds.
Read more »
Eli Lilly’s Mounjaro Approved for Weight Loss in the U.S.The drug, which will be sold as Zepbound as an anti-obesity treatment, had previously been cleared by the FDA for the treatment of Type 2 diabetes
Read more »
GOP Attorneys General Sue FDA over Approval of ‘Risky, Untested’ Mail-Order Abortion PillsThe attorneys general of Missouri, Idaho, and Kansas announced Monday that they are suing the Food and Drug Administration and the U.S. Department ...
Read more »
Missouri attorney general seeks to merge lawsuits against FDA's approval of abortion pill by mailKaelan Deese is a Supreme Court reporter for the Washington Examiner covering the latest happenings at the nation's highest court and the legal issues surrounding Second Amendment rights, abortion, and religious liberties. He previously wrote breaking news as a fellow for the Hill during the 2020 election cycle.
Read more »
FDA banning menthol cigarettes will backfireOne of the most enduring lessons of American history is that the banning of liquor sales and consumption ('the noble experiment') was a colossal failure.
Read more »